The size of the Advanced Visualization Market in the Middle East & Africa has been calculated at USD 0.20 billion in 2022. It is further estimated to be growing at a CAGR of 9.502% and worth USD 0.31 billion by 2027.
Advanced Visualization (AV) refers to 3D and 4D viewing and analysis software for postprocessing of images in the body from the imaging apparatus. The healthcare systems across the world issuing imaging scans, there is a huge need for Advanced visualization (AV) solutions that enable clinicians to efficiently visualize and analyze examination results.
Advanced visualization solutions play a vital role in healthcare organizations as they are used in several imaging modalities as well as clinical areas and are widely adopted in hospitals and diagnostic centers. AV systems include hardware and software applications used in advanced 3D or 4D processing of data acquired by CT, MRI, PET, conventional nuclear medicine and ultrasound.
The market over the world is witnessing growth due to factors such as technological advancements in Advanced Visualization software such as integration of PACS & AV tools, improved diagnostic interpretation with AV tools, rising frequency of target diseases, and rising demand for advanced diagnostic procedures.
However, some factors may restrain market growth such as limited medical reimbursements, technical limitations related to present advanced visualization analysis.
This research report on the Middle East and Africa Advanced Visualization Market segmented and sub-segmented into the following categories:
By Products & Services:
By Solution:
By Imaging Modality:
By Clinical Application:
By End User:
By Country:
Key market participants leading the MEA Advanced Visualization Market Profiled in the Report are General Electric Company, Canon Inc, Siemens AG, Koninklijke Philips N.V, Fujifilm Holdings Corporation, Toshiba Corporation, Terarecon, Inc., Carestream Health, Inc., Pro Medicus Limited, Ziosoft, Agfa-Geveart N.V, and Qi Imaging, LLC.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product and Services
5.1.1 Introduction
5.1.2 Hardware
5.1.3 Software
5.1.4 Services
5.1.5 Y-o-Y Growth Analysis, By Product and services
5.1.6 Market Attractiveness Analysis, By Products and services
5.1.7 Market Share Analysis, By Products and services
5.2 Solution
5.2.1 Introduction
5.2.2 Standalone
5.2.3 Enterprise
5.2.4 Y-o-Y Growth Analysis, By Solution
5.2.5 Market Attractiveness Analysis, By Solution
5.2.6 Market Share Analysis, By Solution
5.3 Imaging Modality
5.3.1 Introduction
5.3.2 Magnetic Resonance Imaging (MRI)
5.3.3 Computed Tomography (CT)
5.3.4 Positron Emission Tomography (PET)
5.3.5 Ultrasound
5.3.6 Radiotherapy (RT)
5.3.7 Nuclear Medicine
5.3.8 Others (PET and SPECT)
5.3.9 Y-o-Y Growth Analysis, By Imaging Modality
5.3.8 Market Attractiveness Analysis, By Imaging Modality
5.3.9 Market Share Analysis, By Imaging Modality
5.4 Clinical Application
5.4.1 Introduction
5.4.2 Radiology
5.4.3 Orthopedics
5.4.4 Cardiac
5.4.5 Neurology
5.4.6 Oncology
5.4.7 Vascular
5.4.8 Neurology
5.4.9 Other diseases
5.4.10 Y-o-Y Growth Analysis, By Clinical Application
5.4.11 Market Attractiveness Analysis, By Clinical Application
5.4.12 Market Share Analysis, By Clinical Application
5.5 End user
5.5.1 Hospitals and Surgical centres
5.5.2 Imaging Centres
5.5.3 Academic and Research Centres
5.5.4 Others
5.5.5 Y-o-Y Growth Analysis, By End user
5.5.6 Market Attractiveness Analysis, By End user
5.5.7 Market Share Analysis, By End user
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product and Services
6.1.3.3 By Solution
6.1.3.4 By Imaging Modality
6.1.3.5 By Clinical Application
6.1.3.6 By End user
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product and Services
6.1.4.3 By Solution
6.1.4.4 By Imaging Modality
6.1.4.5 By Clinical Application
6.1.4.6 By End user
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product and Services
6.1.5.3 By Solution
6.1.5.4 By Imaging Modality
6.1.5.5 By Clinical Application
6.1.5.6 By End user
6.2 Middle-East
6.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 General Electric Company
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Canon Inc
8.3 Siemens AG
8.4 Koninklijke Philips N.V.
8.5 Fujifilm Holdings Corporation
8.6 Toshiba Corporation
8.7 Terarecon Inc
8.8 Carestream Health, Inc
8.9 Pro Medicus Limited
8.10 Ziosoft
8.11 Agfa-Geveart N.V.
8.12 Qi Imaging, LLC
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
